BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31162714)

  • 21. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.
    Zhang Y; Xu G; Liu G; Ye Y; Zhang C; Fan C; Wang H; Cai H; Xiao R; Huang Z; Luo Q
    Biochem Biophys Res Commun; 2016 Aug; 476(4):607-613. PubMed ID: 27264952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-873-5p inhibits cell migration, invasion and epithelial-mesenchymal transition in colorectal cancer via targeting ZEB1.
    Li G; Xu Y; Wang S; Yan W; Zhao Q; Guo J
    Pathol Res Pract; 2019 Jan; 215(1):34-39. PubMed ID: 30455125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
    Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
    Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNA-219-5p inhibits epithelial-mesenchymal transition and metastasis of colorectal cancer by targeting lymphoid enhancer-binding factor 1.
    Huang LX; Hu CY; Jing L; Wang MC; Xu M; Wang J; Wang Y; Nan KJ; Wang SH
    Cancer Sci; 2017 Oct; 108(10):1985-1995. PubMed ID: 28771881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2.
    Li Q; Liang X; Wang Y; Meng X; Xu Y; Cai S; Wang Z; Liu J; Cai G
    Sci Rep; 2016 May; 6():27157. PubMed ID: 27244080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-374b-5p-FOXP1 feedback loop regulates cell migration, epithelial-mesenchymal transition and chemosensitivity in ovarian cancer.
    Li H; Liang J; Qin F; Zhai Y
    Biochem Biophys Res Commun; 2018 Oct; 505(2):554-560. PubMed ID: 30274777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-219a-5p inhibits breast cancer cell migration and epithelial-mesenchymal transition by targeting myocardin-related transcription factor A.
    Zhuang C; Yuan Y; Song T; Wang H; Huang L; Luo X; He H; Huo L; Zhou H; Wang N; Zhang T
    Acta Biochim Biophys Sin (Shanghai); 2017 Dec; 49(12):1112-1121. PubMed ID: 29077787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway.
    Liu G; Wang P; Zhang H
    J Gene Med; 2019 Dec; 21(12):e3129. PubMed ID: 31693779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2.
    Lv ZD; Yang DX; Liu XP; Jin LY; Wang XG; Yang ZC; Liu D; Zhao JJ; Kong B; Li FN; Wang HB
    Cell Physiol Biochem; 2017; 44(5):1785-1795. PubMed ID: 29216628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-142-5p Inhibits Cell Invasion and Migration by Targeting DNMT1 in Breast Cancer.
    Li H; Li HH; Chen Q; Wang YY; Fan CC; Duan YY; Huang Y; Zhang HM; Li JP; Zhang XY; Xiang Y; Gu CJ; Wang L; Liao XH; Zhang TC
    Oncol Res; 2022 Jan; 28(9):885-897. PubMed ID: 34321149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-219-5p targets TBXT and inhibits breast cancer cell EMT and cell migration and invasion.
    Ye Q; Wang X; Yuan M; Cui S; Chen Y; Hu Z; Liu D; Han C; Li B; Chen D
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34339487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-876-5p regulates gastric cancer cell proliferation, apoptosis and migration through targeting WNT5A and MITF.
    Xu Z; Yu Z; Tan Q; Wei C; Tang Q; Wang L; Hong Y
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31171711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 Represses the Oncogenic Sno-MiR-28 Derived from a SnoRNA.
    Yu F; Bracken CP; Pillman KA; Lawrence DM; Goodall GJ; Callen DF; Neilsen PM
    PLoS One; 2015; 10(6):e0129190. PubMed ID: 26061048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide analysis reveals miR-3184-5p and miR-181c-3p as a critical regulator for adipocytes-associated breast cancer.
    Rajarajan D; Selvarajan S; Charan Raja MR; Kar Mahapatra S; Kasiappan R
    J Cell Physiol; 2019 Aug; 234(10):17959-17974. PubMed ID: 30847933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
    Wu M; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu Y; Jin H
    Life Sci; 2020 Aug; 255():117857. PubMed ID: 32470446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.
    Yu Y; Zhao Y; Sun XH; Ge J; Zhang B; Wang X; Cao XC
    Oncotarget; 2015 Oct; 6(33):34423-36. PubMed ID: 26460733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.